Navitus competitors

Mark L. Baum is the founder and CEO of Imprimis Pharmaceuticals whose mission is to provide patients and physicians with innovative and affordable ophthalmic drugs in the ocular surgery, glaucoma, and dry eye disease markets. He is also a founder and board member of Eton Pharmaceuticals and Surface Pharmaceuticals, as well as a board member and chairman of the audit committee of Ideal Power. He was named by Ernst & Young LLP as the 2017 Entrepreneur of the Year™ in the life sciences category for the San Diego region. Prior to Imprimis, as the founder of TBLF, LLC, a private investment fund, He made more than 200 investments into more than 40 private and public companies. In 1999, He founded YesRx, an HIV-focused pharmacy business. He's advocacy for drug pricing and accessibility issues has been reflected as an Op-Ed contributor for the Wall Street Journal and through appearances on CBS, CNN, MSNBC, Fox Business, Bloomberg and Al Jazeera. He is a 1995 cum laude graduate of The University of Texas at Arlington and a 1997 graduate of California Western School of Law.

William Korslin is a Chief Executive Officer at CCS Medical and is based in Harvard, Illinois. He works or has worked as CEO at Centrad Healthcare LLC.

Mr. Luis E. Dini is a Chairman - Chief Executive Officer at Home Solutions and is based in United States.

Mike Ellis is a Chief Executive Officer at Maxor and is based in Dallas/Fort Worth Area. He has worked as Corporate Vice President at walgreen. Mike attended UAMS between 1979 and 1982.

Ken Paulus is a transformative leader with more than 30 years’ experience in the health care sector, building strategic partnerships, integrating payment and delivery systems, and implementing consumer-centric health care solutions. As president and CEO of Prime Therapeutics, Paulus is responsible for the strategic direction and operations of one of the nation’s premier total drug management companies, with more than 28 million members in commercial markets and government programs.

Frederick Howe is Chairman, Chief Executive Officer and founder of MedImpact Healthcare Systems, Inc., the nation's largest privately held full-service pharmacy benefit manager, with 47 million covered lives. Over three decades, Mr. Howe's vision has led to technological breakthroughs and other important changes in the way pharmacy claims are processed and paid every day for millions of consumers. Today, under his leadership, MedImpact is at the forefront of developing new ways to use formularies, disease management and medical data to improve the quality and value of healthcare. He has served on the Schering-Plough Advisory Board and the Scripps Foundation for Medicine and Science, and is an active member in the Academy of Managed Care Pharmacy and several other industry organizations. A dedicated philanthropist, Mr. Howe supports the American Red Cross, Rady Children's Hospital of San Diego, the Leukemia & Lymphoma Society of America, March of Dimes, and the Make-A-Wish Foundation, among many others.

Michael Gavin is a President/CEO at IWP (Injured Workers Pharmacy) and is based in Atlanta, Georgia. He has worked as Senior Manager at Kurt Salmon, VP of Operations at SPH Analytics, and Consultant at Monitor Group. Michael works or has worked as VP:Operations at MDdatacor and President at PRIUM. He studied at Emory University between 2006 and 2007, Emory University - Goizueta Business School between 2006 and 2007, and Georgetown McDonough School of Business between 1997 and 2000.

Marshall Thomas is a Founding Executive Director at Helen and Arthur E. Johnson Depression Center at the University of Colorado, President and CEO at COLORADO ACCESS, and Professor of Psychiatry and Family Medicine at University of Colorado and is based in Denver, Colorado. He attended The University of Texas at Austin between 1972 and 1976 and Baylor College of Medicine between 1976 and 1980.